Reuters Health Information (2004-11-09): UK scientists seek liver failure patients for stem cell therapy
UK scientists seek liver failure patients for stem cell therapy
Last Updated: 2004-11-09 12:17:33 -0400 (Reuters Health)
LONDON (Agence de Presse Medicale for Reuters Health) -
British scientists said on Tuesday they were looking for patients with
chronic liver failure to take part in a trial of stem cell therapy.
The team, from Imperial College London and Hammersmith Hospital,
said injecting the patient's own blood-derived stem cells directly into
the hepatic artery might improve liver function by getting the stem
cells to repopulate the liver.
Professor Nagy Habib, trial leader, said in a statement: "Although
this is still very early days for the trial, it could be a first step
to providing a new treatment option for those suffering from chronic
The researchers said the trial would involve 13 hospital visits over
2 months for various procedures, including leukapheresis to separate
the stem cells from the white blood cells. Patients would have to visit
the hospital every 2 weeks for liver function, kidney and blood
Dr. Habib was not immediately available to explain why he thinks
stem cell therapy will be effective against liver failure or whether
there are any safety concerns.